Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Hum Genet ; 134(10): 1089-97, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26264464

ABSTRACT

KCNH1 mutations have recently been described in six individuals with Temple-Baraitser syndrome (TMBTS) and six individuals with Zimmermann-Laband syndrome (ZLS). TMBTS is characterized by intellectual disability (ID), epilepsy, dysmorphic facial features, broad thumbs and great toes with absent/hypoplastic nails. ZLS is characterized by facial dysmorphism including coarsening of the face and a large nose, gingival enlargement, ID, hypoplasia of terminal phalanges and nails and hypertrichosis. In this study, we present four additional unrelated individuals with de novo KCNH1 mutations from ID cohorts. We report on a novel recurrent pathogenic KCNH1 variant in three individuals and add a fourth individual with a previously TMBTS-associated KCNH1 variant. Neither TMBTS nor ZLS was suspected clinically. KCNH1 encodes a voltage-gated potassium channel, which is not only highly expressed in the central nervous system, but also seems to play an important role during development. Clinical evaluation of our mutation-positive individuals revealed that one of the main characteristics of TMBTS/ZLS, namely the pronounced nail hypoplasia of the great toes and thumbs, can be mild and develop over time. Clinical comparison of all published KCNH1 mutation-positive individuals revealed a similar facial but variable limb phenotype. KCNH1 mutation-positive individuals present with severe ID, neonatal hypotonia, hypertelorism, broad nasal tip, wide mouth, nail a/hypoplasia, a proximal implanted and long thumb and long great toes. In summary, we show that the phenotypic variability of individuals with KCNH1 mutations is more pronounced than previously expected, and we discuss whether KCNH1 mutations allow for "lumping" or for "splitting" of TMBTS and ZLS.


Subject(s)
Abnormalities, Multiple/genetics , Craniofacial Abnormalities/genetics , Ether-A-Go-Go Potassium Channels/genetics , Fibromatosis, Gingival/genetics , Hallux/abnormalities , Hand Deformities, Congenital/genetics , Intellectual Disability/genetics , Nails, Malformed/genetics , Thumb/abnormalities , Abnormalities, Multiple/pathology , Adolescent , Child, Preschool , Craniofacial Abnormalities/pathology , Female , Fibromatosis, Gingival/pathology , Hallux/pathology , Hand Deformities, Congenital/pathology , Humans , Intellectual Disability/pathology , Mutation, Missense , Nails, Malformed/pathology , Thumb/pathology
2.
Hum Genet ; 132(8): 885-98, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23568615

ABSTRACT

Nager syndrome (MIM #154400) is the best-known preaxial acrofacial dysostosis, mainly characterized by craniofacial and preaxial limb anomalies. The craniofacial abnormalities mainly consist of downslanting palpebral fissures, malar hypoplasia, micrognathia, external ear anomalies, and cleft palate. The preaxial limb defects are characterized by radial and thumb hypoplasia or aplasia, duplication of thumbs and proximal radioulnar synostosis. Haploinsufficiency of SF3B4 (MIM *605593), which encodes SAP49, a component of the pre-mRNA spliceosomal complex, has recently been identified as the underlying cause of Nager syndrome. In our study, we performed exome sequencing in two and Sanger sequencing of SF3B4 in further ten previously unreported patients with the clinical diagnosis of Nager syndrome, including one familial case. We identified heterozygous SF3B4 mutations in seven out of twelve patients. Four of the seven mutations were shown to be de novo; in three individuals, DNA of both parents was not available. No familial mutations were discovered. Three mutations were nonsense, three were frameshift mutations and one T > C transition destroyed the translation start signal. In three of four SF3B4 negative families, EFTUD2 was analyzed, but no pathogenic variants were identified. Our results indicate that the SF3B4 gene is mutated in about half of the patients with the clinical diagnosis of Nager syndrome and further support genetic heterogeneity for this condition.


Subject(s)
Exome/genetics , Mandibulofacial Dysostosis/genetics , Mutation/genetics , RNA Precursors/genetics , RNA-Binding Proteins/genetics , Spliceosomes/genetics , Adolescent , Adult , Child, Preschool , Female , Genetic Association Studies , Humans , Infant , Male , Mandibulofacial Dysostosis/diagnosis , RNA Splicing Factors
3.
Brain Res Bull ; 81(1): 157-63, 2010 Jan 15.
Article in English | MEDLINE | ID: mdl-19818386

ABSTRACT

It is known that application of tumor-necrosis-factor-alpha (TNF-alpha) sensitizes neuronal calcium channels for heat stimuli in rat models of neuropathic pain. This study examines whether TNF-alpha modulates the capsaicin-induced effects after transient receptor potential vanilloid (TRPV)-1 receptor activation on voltage activated calcium channel currents (I(Ca(V))). TRPV-1 receptors are activated by heat and play an important role in the pathogenesis of thermal hyperalgesia in neuropathic pain syndromes, while voltage activated channels are essential for transmission of neuronal signals. Eliciting I(Ca(V)) in DRG neurons of rats by a depolarization from the resting potential to 0 mV, TNF-alpha (100 ng/ml) reduces I(Ca(V)) by 16.9+/-2.2%, while capsaicin (0.1 microM) decreases currents by 27+/-4.3%. Pre-application of TNF-alpha (100 ng/ml) for 24h results in a sensitization of I(Ca(V)) to capsaicin (0.1 microM) with a reduction of 42.8+/-4.4% mediated by TRPV-1. While L-type (36.6+/-5.2%) and P/Q-type currents (35.6+/-4.1%) are also sensitized by TRPV-1 activation, N-type channel currents are most sensitive (74.5+/-7.3%). The capsaicin-induced shift towards the hyperpolarizing voltage range does not occur when TNF-alpha is applied. Summarizing, TNF-alpha sensitizes nociceptive neurons for capsaicin.


Subject(s)
Calcium Channels/metabolism , Capsaicin/pharmacology , Membrane Potentials/drug effects , Nociceptors/drug effects , Sensory System Agents/pharmacology , Tumor Necrosis Factor-alpha/metabolism , Animals , Calcium Channels, L-Type/metabolism , Calcium Channels, N-Type/metabolism , Calcium Channels, P-Type/metabolism , Calcium Channels, Q-Type/metabolism , Cells, Cultured , Ganglia, Spinal/drug effects , Ganglia, Spinal/physiology , Membrane Potentials/physiology , Nociceptors/physiology , Patch-Clamp Techniques , Rats , Rats, Wistar , TRPV Cation Channels/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL